BioCentury | Jan 29, 2015
Product R&D

Company checkpoints

...tumor-infiltrating lymphocytes. Markel is the scientific founder and CSO of cCAM and chief scientist at Chaim Sheba Medical Center...
...for Cancer Research, Philadelphia, Pa. AnaptysBio Inc., San Diego, Calif. cCAM Biotherapeutics Ltd., Misgav, Israel Chaim Sheba Medical Center...
BioCentury | Jan 9, 2014
Tools & Techniques

Silencing KRAS

...paper included researchers from Tel Aviv University , The Hebrew University of Jerusalem , the Chaim Sheba Medical Center...
...Martz, L. SciBX 7 (1); doi:10.1038/scibx.2014.4 Published online Jan. 9, 2014 Companies and Institutions Mentioned Chaim Sheba Medical Center...
BioCentury | Apr 16, 2012
Company News

Orgenesis, Tel Hashomer Medical Research Infrastructure and Services Ltd. deal

...therapy for diabetes under the supervision of Orgenesis. The trial will be conducted at the Chaim Sheba Medical Center...
BioCentury | Apr 9, 2012
Company News

Orgenesis management update

...Ltd.; Sarah Ferber as CSO, head researcher of the endocrine unit at The Endocrine Institute, Chaim Sheba Medical Center...
BioCentury | Jan 30, 2012
Clinical News

Zevalin ibritumomab tiuxetan: Phase III data

...Researchers at the Chaim Sheba Medical Center and colleagues reported data from an open-label, Israeli Phase III trial in...
Items per page:
1 - 5 of 5
BioCentury | Jan 29, 2015
Product R&D

Company checkpoints

...tumor-infiltrating lymphocytes. Markel is the scientific founder and CSO of cCAM and chief scientist at Chaim Sheba Medical Center...
...for Cancer Research, Philadelphia, Pa. AnaptysBio Inc., San Diego, Calif. cCAM Biotherapeutics Ltd., Misgav, Israel Chaim Sheba Medical Center...
BioCentury | Jan 9, 2014
Tools & Techniques

Silencing KRAS

...paper included researchers from Tel Aviv University , The Hebrew University of Jerusalem , the Chaim Sheba Medical Center...
...Martz, L. SciBX 7 (1); doi:10.1038/scibx.2014.4 Published online Jan. 9, 2014 Companies and Institutions Mentioned Chaim Sheba Medical Center...
BioCentury | Apr 16, 2012
Company News

Orgenesis, Tel Hashomer Medical Research Infrastructure and Services Ltd. deal

...therapy for diabetes under the supervision of Orgenesis. The trial will be conducted at the Chaim Sheba Medical Center...
BioCentury | Apr 9, 2012
Company News

Orgenesis management update

...Ltd.; Sarah Ferber as CSO, head researcher of the endocrine unit at The Endocrine Institute, Chaim Sheba Medical Center...
BioCentury | Jan 30, 2012
Clinical News

Zevalin ibritumomab tiuxetan: Phase III data

...Researchers at the Chaim Sheba Medical Center and colleagues reported data from an open-label, Israeli Phase III trial in...
Items per page:
1 - 5 of 5